Source:http://linkedlifedata.com/resource/pubmed/id/10189215
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
7183
|
pubmed:dateCreated |
1999-3-30
|
pubmed:commentsCorrections | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
0959-8138
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
27
|
pubmed:volume |
318
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
602-3; author reply 603-4
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:10189215-Anticholesteremic Agents,
pubmed-meshheading:10189215-Cholesterol,
pubmed-meshheading:10189215-Enzyme Inhibitors,
pubmed-meshheading:10189215-Humans,
pubmed-meshheading:10189215-Hydroxymethylglutaryl-CoA Reductase Inhibitors,
pubmed-meshheading:10189215-Hypercholesterolemia
|
pubmed:year |
1999
|
pubmed:articleTitle |
Communicating risk reductions. One example is not enough.
|
pubmed:publicationType |
Letter,
Comment
|